Logo of envhperLink to Publisher's site
Environ Health Perspect. 1987 Nov; 75: 53–57.
doi: 10.1289/ehp.877553
PMCID: PMC1474447
PMID: 3319565
Research Article

Possible neurologic effects of aspartame, a widely used food additive.

T J Maher and R J Wurtman
Author information Copyright and License information Disclaimer

Abstract

The artificial sweetener aspartame (L-aspartyl-L-phenylalanyl-methyl ester), is consumed, primarily in beverages, by a very large number of Americans, causing significant elevations in plasma and, probably, brain phenylalanine levels. Anecdotal reports suggest that some people suffer neurologic or behavioral reactions in association with aspartame consumption. Since phenylalanine can be neurotoxic and can affect the synthesis of inhibitory monoamine neurotransmitters, the phenylalanine in aspartame could conceiveably mediate neurologic effects. If mice are given aspartame in doses that elevate plasma phenylalanine levels more than those of tyrosine (which probably occurs after any aspartame dose in humans), the frequency of seizures following the administration of an epileptogenic drug, pentylenetetrazole, is enhanced. This effect is simulated by equimolar phenylalanine and blocked by concurrent administration of valine, which blocks phenylalanine's entry into the brain. Aspartame also potentiates the induction of seizures by inhaled fluorothyl or by electroconvulsive shock. Perhaps regulations concerning the sale of food additives should be modified to require the reporting of adverse reactions and the continuing conduct of mandated safety research.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

 
icon of scanned page 53
53
icon of scanned page 54
54
icon of scanned page 55
55
icon of scanned page 56
56
icon of scanned page 57
57
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Wurtman RJ, Maher TJ. Strategies for assessing the effects of food additives on the brain and behavior. Fundam Appl Toxicol. 1984 Jun;4(3 Pt 2):S318–S322. [PubMed] [Google Scholar]
  • Bradstock MK, Serdula MK, Marks JS, Barnard RJ, Crane NT, Remington PL, Trowbridge FL. Evaluation of reactions to food additives: the aspartame experience. Am J Clin Nutr. 1986 Mar;43(3):464–469. [PubMed] [Google Scholar]
  • Johns DR. Migraine provoked by aspartame. N Engl J Med. 1986 Aug 14;315(7):456–456. [PubMed] [Google Scholar]
  • Ferguson JM. Interaction of aspartame and carbohydrates in an eating-disordered patient. Am J Psychiatry. 1985 Feb;142(2):271–271. [PubMed] [Google Scholar]
  • Drake ME. Panic attacks and excessive aspartame ingestion. Lancet. 1986 Sep 13;2(8507):631–631. [PubMed] [Google Scholar]
  • Wurtman RJ. Aspartame: possible effect on seizure susceptibility. Lancet. 1985 Nov 9;2(8463):1060–1060. [PubMed] [Google Scholar]
  • Walton RG. Seizure and mania after high intake of aspartame. Psychosomatics. 1986 Mar;27(3):218–220. [PubMed] [Google Scholar]
  • Stegink LD, Filer LJ, Jr, Baker GL. Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acid levels in normal adult volunteers. J Nutr. 1977 Oct;107(10):1837–1845. [PubMed] [Google Scholar]
  • Fernstrom JD, Fernstrom MH, Gillis MA. Acute effects of aspartame on large neutral amino acids and monoamines in rat brain. Life Sci. 1983 Apr 4;32(14):1651–1658. [PubMed] [Google Scholar]
  • Ranney RE, Oppermann JA, Muldoon E, McMahon FG. Comparative metabolism of aspartame in experimental animals and humans. J Toxicol Environ Health. 1976 Nov;2(2):441–451. [PubMed] [Google Scholar]
  • Fernstrom JD, Wurtman RJ, Hammarstrom-Wiklund B, Rand WM, Munro HN, Davidson CS. Diurnal variations in plasma concentrations of tryptophan, tryosine, and other neutral amino acids: effect of dietary protein intake. Am J Clin Nutr. 1979 Sep;32(9):1912–1922. [PubMed] [Google Scholar]
  • Maher TJ, Glaeser BS, Wurtman RJ. Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake. Am J Clin Nutr. 1984 May;39(5):722–729. [PubMed] [Google Scholar]
  • Stegink LD, Filer LJ, Jr, Baker GL, McDonnell JE. Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults. J Nutr. 1980 Nov;110(11):2216–2224. [PubMed] [Google Scholar]
  • Fernstrom JD, Faller DV. Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem. 1978 Jun;30(6):1531–1538. [PubMed] [Google Scholar]
  • Elwyn DH, Parikh HC, Shoemaker WC. Amino acid movements between gut, liver, and periphery in unanesthetized dogs. Am J Physiol. 1968 Nov;215(5):1260–1275. [PubMed] [Google Scholar]
  • Oldendorf WH. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol. 1971 Dec;221(6):1629–1639. [PubMed] [Google Scholar]
  • Levy HL, Waisbren SE. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus. N Engl J Med. 1983 Nov 24;309(21):1269–1274. [PubMed] [Google Scholar]
  • Jobe PC, Dailey JW, Reigel CE. Noradrenergic and serotonergic determinants of seizure susceptibility and severity in genetically epilepsy-prone rats. Life Sci. 1986 Sep 1;39(9):775–782. [PubMed] [Google Scholar]
  • Milner JD, Irie K, Wurtman RJ. Effects of phenylalanine on the release of endogenous dopamine from rat striatal slices. J Neurochem. 1986 Nov;47(5):1444–1448. [PubMed] [Google Scholar]
Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences